Drug shortage
Amphetamine Aspartate Monohydrate · SpecGx LLC
FDA drug shortage · Current · updated Apr 15, 2025
Key facts
| Generic name | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet |
|---|---|
| Proprietary name | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate |
| Company | SpecGx LLC |
| Presentation | Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01) |
| Dosage form | Tablet |
| Strength | 5 mg |
| Status | Current |
| Reason for shortage | Shortage of an active ingredient |
| Therapeutic category | Psychiatry |
| Package NDCs | 0406-8893-01 |
| First posted | Oct 12, 2022 |
| Last updated | Apr 15, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: